NCT07256236 2026-03-30
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
Fujian Cancer Hospital
Phase 2 Recruiting
Clinical Trials
25 trialsNCT07472153 2026-03-16
PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer
N.N. Alexandrov National Cancer Centre
Phase 2/3 Recruiting
NCT07435623 2026-03-02
Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study
Tata Memorial Hospital
Recruiting
NCT05102240 2026-02-20
Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer
Tata Memorial Hospital
Recruiting
NCT06644846 2026-02-20
Spatially Fractionated Radiation Treatment for Gynaecological Cancers
Tata Memorial Hospital
Phase NA Recruiting
NCT03997110 2026-02-17
RAPPAL
Tata Memorial Hospital
Phase NA Recruiting
NCT07400809 2026-02-17
Retro-COSMOS
Tata Memorial Hospital
Recruiting
NCT06804135 2026-02-04
STIRR
Tata Memorial Hospital
Recruiting
NCT07290972 2026-02-04
NCG-Compliance
Tata Memorial Hospital
Recruiting
NCT07050745 2026-01-12
DADA-LINK
Kenyatta National Hospital
Phase NA Recruiting
NCT07181278 2025-12-02
OptiTri_MT
Institut de Recherche pour le Developpement
Phase NA Recruiting
NCT06560697 2025-10-07
SABRVICAL
National Institute of CancerologĂa
Phase NA Recruiting
NCT07177170 2025-09-16
OptiTri_GC
Institut de Recherche pour le Developpement
Phase NA Recruiting
NCT07106814 2025-09-15
Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Anhui Provincial Hospital
Phase EARLY_PHASE1 Recruiting
NCT07055399 2025-09-11
NICE-CC
Fujian Cancer Hospital
Phase 2 Recruiting
NCT06967740 2025-07-31
Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs
Faculty Hospital Kralovske Vinohrady
Recruiting
NCT06232083 2025-07-09
A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
Anhui Provincial Hospital
Phase 1 Recruiting
NCT03101995 2025-05-28
Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease
National Institute of CancerologĂa
Phase 2 Recruiting
NCT06528184 2025-02-10
Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings
National Healthcare Group Polyclinics
Phase NA Recruiting
NCT05855941 2024-12-16
PRODIGYN
Region VĂ€sterbotten
Recruiting
NCT06140589 2024-09-19
Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer
Fujian Cancer Hospital
Recruiting
NCT06455072 2024-06-12
Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer
Fujian Cancer Hospital
Phase 2 Recruiting
NCT06253169 2024-04-23
ASTRA
Patient Organization Veronica
Recruiting
NCT05910177 2024-03-06
Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin
Fujian Cancer Hospital
Phase 2 Recruiting
NCT04910802 2021-09-16
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
Region Stockholm
Phase 4 Recruiting